✦ LIBER ✦

Estrogen receptor status and adjuvant polychemotherapy or antiestrogen therapy in patients with high-risk breast cancer

✍ Scribed by W. Jonat; H. Maass; M. Braun; G. Winter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progesterone receptor status provides pr

✍ Ke-Da Yu; Guang-Yu Liu; Gen-Hong Di; Jiong Wu; Jin-Song Lu; Kun-Wei Shen; Zhen-Z 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Adjuvant trastuzumab use in high-risk br

✍ Kadri Altundag; Ozden Altundag; Rabiul Islam; Ozlem Gundeslioglu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Direct comparisons of adjuvant endocrine

✍ Yasuo Nomura; Mitsunori Shirouzu; Takahiro Takayama 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 701 KB

59 Adjuvant therapy for stage II or III

✍ W. Jonat; H. Maass; M. Braun 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Overview of randomized trials in high ri

✍ Marie Overgaard 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 768 KB

Cyclophosphamide, methotrexate, and fluo

✍ Bent Ejlertsen; Henning T. Mouridsen; Maj-Britt Jensen; Jørn Andersen; Michael A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB